1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Industry in European Union Market Research & Statistics

Cancer Industry in European Union Market Research & Statistics

Customer Support

Talk to Sam

+1 646 893 5945

All regions

42 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Global Therapy Market and Oncology Market

  • January 2020
  • 108 pages
  • Cancer
  • Oncology
  • Therapy
  • European Union
  • OECD
View report >

Cancer Statistics in EU

  • November 2019
  • 12 pages
  • Cancer
  • Health Services
  • Pathology
  • European Union
  • Demographic
View report >

Pharmaceutical Market in Europe

  • June 2019
  • 132 pages
  • Cancer
  • HIV AIDS
  • European Union
  • Economy
  • Market Size
View report >

Cancer Statistics in EU

  • October 2018
  • 12 pages
  • Cancer
  • Health Services
  • Pathology
  • European Union
  • Demographic
View report >

Colorectal Cancer Statistics in EU

  • October 2018
  • 17 pages
  • Cancer
  • Colorectal Cancer
  • Pathology
  • European Union
  • Demographic
View report >

Healthcare Demographic Impact in Europe

  • January 2018
  • 216 pages
  • Cancer
  • Healthcare
  • HIV AIDS
  • European Union
  • Demographic
View report >

Cancer Statistics in OECD Countries - Forecast

  • January 2018
  • 3 pages
  • Cancer
  • Pathology
  • European Union
  • OECD
  • Forecast
View report >

Therapy Market - Forecast

  • August 2017
  • 9 pages
  • Cancer
  • European Union
  • Demand
  • Market Size
  • Roche Group
View report >

The future of the Healthcare Social Impact in EU

  • January 2017
  • 30 pages
  • Ambulatory Care
  • Cancer
  • Healthcare
  • Estonia
  • European Union
View report >

Cancer Statistics in EU

  • February 2016
  • 5 pages
  • Cancer
  • Pathology
  • European Union
  • Demographic Indicators

Search in Cancer Industry (42 reports)
Parent industry: Pathology
Related industries: Chronic Disease, Mental Health

About 100 reports

Purchase Reports From Reputable Market Research Publishers

Stivarga

  • $ 10000
  • September 2019
  • 30 pages

Drug Overview Stivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Cancer
  • Colorectal Cancer
  • Hepatitis
  • Pathology
  • European Union

Nexavar $ 10000 September 2019

Lenvima $ 10000 September 2019

Tecentriq $ 10000 September 2019

Opdivo $ 10000 September 2019

Cyramza $ 10000 September 2019

Imfinzi $ 10000 September 2019

Keytruda $ 10000 September 2019

Cabometyx $ 10000 September 2019

Votrient $ 10000 March 2019


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on